Ophthalmic BSS are sterile, isotonic, irrigating solutions used during surgical procedures of the eye.

Michelle Hessen, OD, spoke about the results of a new study evaluating the efficacy of cyclosporine ophthalmic solution 0.09% in patients with dry eye. Michelle Hessen, OD, assistant professor of ...

The FDA has approved Pataday Once Daily Relief Extra Strength (olopatadine hydrochloride 0.7%; Alcon) ophthalmic solution, formerly prescribed as Pazeo®, for sale over-the-counter.

On May 18 th, 2023, U.S. Food and Drug Administration (FDA) approved MIEBO™ (perfluorohexyloctane ophthalmic solution; formerly known as NOV03) followed by the approval of VEVYE™ (cyclosporine ...

Ocuphire Pharma has dosed the first participants in the VEGA-3 phase 3 clinical trial investigating phentolamine ophthalmic solution 0.75% for the treatment of presbyopia, according to a press ...

Opus Genetics (IRD) said that the FDA has granted Fast Track designation for Phentolamine Ophthalmic Solution 0.75% as a potential treatment for chronic night driving impairment and debilitating ...

Amring Pharmaceuticals Inc. Announces the Launch of Timolol Maleate Ophthalmic Solution, USP 0.5% June 23, 2022 08:30 AM Eastern Daylight Time ...

The FDA granted fast track designation to phentolamine ophthalmic solution 0.75% to treat significant chronic night driving impairment in patients who have undergone keratorefractive surgery.

Session ID: 2025-06-15:e21368dadcfb40bb4d32bce7 Player Element ID: vjs_video_3 ...

A Phase 2 Trial to Test Safety and Efficacy of ST-100, a Unique Collagen Mimetic Peptide Ophthalmic Solution for Dry Eye Disease. Ophthalmol Sci. 2023 Dec 12;4 (3):100451. doi: 10.1016/j.xops.2023 ...

The VEGA-3 trial met its primary endpoint, with a statistically significant 27.2% of participants treated with Phentolamine Ophthalmic Solution 0.75% achieving a ≥15-letter improvement in ...